Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-28 @ 6:12 AM
Study NCT ID:
NCT04857957
Status:
COMPLETED
Last Update Posted:
2025-07-28
First Post:
2021-04-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN
Sponsor:
Centrexion Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CNTX-6016o-HV/PDN-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None